A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants

Inclusion Criteria: * Body mass index between 18 and 30 kilograms/meter squared inclusive, at the screening visit. * Japanese participants must be of Japanese descent (both biological parents are ethnically Japanese). * Caucasian participants must be of European or Latin American Caucasian descent. * A female participant is eligible to participate if she is a woman of nonchildbearing potential as defined in the protocol. * Males who are sexually active with woman of childbearing potential must agree to follow protocol-defined instructions for method(s) of contraception. Exclusion Criteria: * Any acute or chronic medical illness. * Active infection, including with coronavirus disease-19, diagnosed clinically by the investigator. * History of any other clinically significant disorder, condition, or disease that, in the opinion of the investigator or sponsor clinical trial physician, would pose a risk to participant safety or interfere with the study evaluation, procedures, or completion. Note: Other protocol-defined inclusion/exclusion criteria apply.